RT Journal Article
SR Electronic
T1 In-depth Analysis of Laboratory Parameters Reveals the Interplay Between Sex, Age and Systemic Inflammation in Individuals with COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.07.20170043
DO 10.1101/2020.08.07.20170043
A1 tem-Caten, Felipe
A1 Gonzalez-Dias, Patrícia
A1 Castro, Ícaro
A1 Ogava, Rodrigo L T
A1 Giddaluru, Jeevan
A1 Silva, Juan Carlo S
A1 Martins, Felipe
A1 Gonçalves, André N A
A1 Costa-Martins, André G
A1 Araujo, José D.
A1 Viegas, Ana Carolina
A1 Cunha, Fernando Q
A1 Farsky, Sandra
A1 Bozza, Fernando A
A1 Levin, Anna S
A1 Pannaraj, Pia S
A1 de Silva, Thushan I
A1 Minoprio, Paola
A1 Andrade, Bruno B
A1 da Silva, Fabiano Pinheiro
A1 Nakaya, Helder I
YR 2020
UL http://medrxiv.org/content/early/2020/08/11/2020.08.07.20170043.abstract
AB Introduction The progression and severity of the coronavirus disease 2019 (COVID-19), an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), varies significantly in the population. While the hallmarks of SARS-CoV-2 and severe COVID-19 within routine laboratory parameters are emerging, little is known about the impact of sex and age on these profiles.Methods We performed multidimensional analysis of millions of records of laboratory parameters and diagnostic tests for 178,887 individuals, of which 33,266 tested positive for SARS-CoV-2. These included complete blood cell count, electrolytes, metabolites, arterial blood gases, enzymes, hormones, cancer biomarkers, and others.Results COVID-19 induced more alterations in the laboratory parameters in males compared to females between 13 and 60 years old, in contrast to older individuals, where several parameters were altered by COVID-19 in both men and women. Biomarkers of inflammation, such as C-reactive protein (CRP) and ferritin, were increased especially in older men with COVID-19, whereas other markers such as abnormal liver function tests were common across several age groups, except for young women. Low peripheral blood basophils and eosinophils were also more common in the elderly with COVID-19. Both male and female COVID-19 patients admitted to the intensive care unit (ICU) displayed alterations in the coagulation system, and higher levels of neutrophils, CRP, lactate dehydrogenase (LDH), among others.Discussion Our study uncovers the laboratory profile of a large cohort of COVID-19 patients that underly discrepancies influenced by aging and biological sex. These profiles directly link COVID-19 disease presentation to an intricate interplay between sex, age and the immune response.One Sentence Summary Big Data analysis of laboratory results from a large number of COVID-19 patients and controls reveals distinct disease profiles influenced by age and sex which may underly occurrence of severe disease.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot appliedFunding StatementThis work was supported by Brazilian National Council for Scientific and Technological Development (grant number 313662/2017-7 to H. I. N.); the Sao Paulo Research Foundation (grant numbers 2018/14933-2 to H.I.N. and P.M.; 2018/21934-5 to H.I.N; 2017/27131-9 to H.I.N. and P.M.; 2013/08216-2 to F.Q.C. and H. I. N.; 2019/27139-5 to J.C.S.S.; 2019/13880-5 to A.N.A.G.); Fundacao Faculdade de Medicina (TO 206.304); and CAPES.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the original data is available at https://repositoriodatasharingfapesp.uspdigital.usp.br/. https://repositoriodatasharingfapesp.uspdigital.usp.br/